Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
05/29/2003
Trade Name:
Prinivil
Generic Name or Proper Name (*):
lisinopril
Indications Studied:
Hypertension
Label Changes Summary:
* Labeling for 6-16 years of age * Not recommended for pediatric patients with glomerular filtration rate < 30ml/min/1.73m2 * Information on dose, efficacy and pharmacokinetics * No relevant differences were identified between adverse experience profile for pediatric patients and that previously reported for adult patients * Information on preparation of a suspension
Product Labeling:
Labeling
BPCA(B):
B
Sponsor:
Merck
Pediatric Exclusivity Granted Date:
11/19/2001
NNPS:
FALSE
Therapeutic Category:
Antihypertensive
-
-